Does bariatric surgery cure the metabolic syndrome?;Cirurgia bariátrica cura a síndrome metabólica?

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 2, 2006, Pages 400-407

  Geloneze, Bruno ^a   Pareja, José Carlos ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bariatric surgery; Cardiovascular mortality; Diabetes mellitus; Metabolic syndrome; Obesity; Surgical risk

Indexed keywords

BARIATRIC SURGERY; HUMAN; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REVIEW; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; OBESITY, MORBID; WEIGHT LOSS;

EID: 33744468249     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302006000200026     Document Type: Review

References (45)

1. Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg 2003;13:329-30.
2. Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
3. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol 2004;24:e19-24.
4. Staels B, Fruchart JC. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005;54:2460-70.
5. Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002;10(suppl. 2):97S-104S.
6. Garow JS. Treatment of morbid obesity by nonsurgical means: diet, drugs, behavior modification, exercise. Gastroenterol Clin Am North 1987;16:443-9.
7. Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterol 2001;120:669-81.
8. Bushwald H, Avidor Y, Braunwad E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery. A systematic review and meta-analysis. JAMA 2004;292:1724-37.
9. Pories WJ, MacDonald KG, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 1992;55:582-5S.
10. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2283-93.
11. Ferchak CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes - a systematic review. Diabetes Metab Res Rev 2004;20:438-45.
12. Eisenberg D, Bell RL. The impact of bariatric surgery on severely obese patients with diabetes. Diabetes Spectrum 2003;16:240-5.
13. Muscelli E, Mingrone G, Camastra S, Manco M, Pereira JA, Pareja JC, et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 2005;118:51-7.
14. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004;89:2608-15.
15. Geloneze B, Repetto EM, Pilla VF, Tambascia MA, Pareja JC. Ghrelin a gut-brain hormone. Effect of gastric bypass. Obes Surg 2003;13:17-22.
16. Polyzogopolou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003;52:1098-103.
17. Valverde I, Puente J, Martin-Duce A, Molina L, Lozano O, Sancho V, et al. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg 2005;15:387-97.
18. Adami G, Murelli F, Carlini F, Papadia F, Scopinaro N. Long-term effect of biliopancreatic diversion on blood pressure in hypertensive obese patients. Am J Hypertens 2005;18:780-4.
19. Buffington CK, Cowan GS Jr, Smith H. Significant changes in the lipid-lipoprotein status of premenopausal morbidly obese females following gastric bypass surgery. Obes Surg 1994;4:328-35.
20. Geloneze B, Tambascia MA, Pareja JC, Repetto EM, Magna LA, Pereira SG. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes. Obes Surg 2001;11:693-8.
21. Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am 2001;81:1063-75.
22. Agnani S, Vachharajani VT, Gupta R, Atray NK, Vachharajani TJ. Does treating obesity stabilize chronic kidney disease? BMC Nephrol 2005;15;6-7.
23. Geloneze B, Repetto EM, Pareja JC, Tambascia MA. The insulin tolerance test in morbidly obese patients undergoing bariatric surgery. Obes Res 2001;9:763-9.
24. Pereira JA, Claro BM, Pareja JC, Chaim EA, Astiarraga BD, Saad MJ, et al. Restored insulin inhibition on insulin secretion in nondiabetic severely obese patients after weight loss induced by bariatric surgery. Int J Obes Relat Metab Disord 2003;27:463-8.
25. Lima MOL, Pareja JC, Tambascia MA, Repetto EM, Thé C, Geloneze B. Insulin Sensitivity after Gastric Bypass. A 6-Year Prospective Study. Diabetes 2005;54:A203.
26. Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol 2005;152:501-13.
27. Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J, San Millan JL. The polycystic ovary syndrome Associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005;90:6364-9.
28. Erhmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-6.
29. Byrne TK. Complications of surgery for obesity. Surg Clin North Am 2001;81:1181-93.
30. van Dielen FMH, Buurman WA, Hadfoune M, Nijhuis J, Greve JW. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 2004;89:4062-8.
31. Willians IL, Chowienczyk PJ, Wheatcroft SB, Patel AG, Sherwood RA, Momin A, et al. Endothelial function and weight loss in obese humans. Obes Surg 2005;15:1055-60.
32. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
33. Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg 2005;15:692-9.
34. Geloneze B, Pereira J, Pareja J, Souza A, Tambascia M, Muscelli E. Circulating concentrations of adiponectin increase in parallel with enhancement of insulin sensitivity in humans. Diabetes 2003;52(suppl. 1):A393.
35. den Boer M, Voshol PJ, Kuipers F, Havekes LM, Romijn JA. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol 2004;24:644-9.
36. Mottin CC, Moretto M, Padoin AV, Kupski C, Swarowsky AM, Glock L, et al. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg 2005;15:788-93.
37. Geloneze B, Geloneze SR, Picolo M, Repetto EM, Murro AL, Tambascia MA. Metabolic syndrome as a surgical condition. Obes Surg 2002;12:459.
38. Carvalho PS, Barelli MC, Moreira CLCB, Oliveira FH, Guzzo MF, Miguel GSP, et al. Cirurgia bariátrica cura diabetes? Arq Bras Endocrinol Metab 2005;49.
39. Inzucchi SE, Sherwin RS. The prevention of type 2 diabetes mellitus. Endocrinol Metab Clin North Am 2005;34:199-219.
40. Long SD, O'Brien K, MacDonald KG Jr, Leggett-Frazier N, Swanson MS, Pories WJ, et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 1994;17:372-5.
41. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. National Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Am J Epidemiol 1999;149:491-503.
42. Sjostrom CD, Peltonen M, Sjostrom L. Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study. Obes Res 2001;9:188-95.
43. MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, et al. The gastric bypass operation reduces the progression and mortality of non-insulindependent diabetes mellitus. J Gastrointest Surg 1999;1:213-20.
44. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240:416-23.
45. Hickey MS, Pories WJ, MacDonald KG Jr, Cory KA, Dohm GL, Swanson MS, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 1998;227:637-43.